← Back to Search

Wearable Biosensors for Autoimmune Epilepsy

N/A

Waitlist Available

Led By Benjamin Brinkmann, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients diagnosed with or suspected of having autoimmune epilepsy

Normal controls - cognitively normal subjects without epilepsy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 days

Awards & highlights

Study Summary

This trial seeks to detect physical signals that can help predict epileptic seizures, such as heart rate, muscle activity and EEG.

Who is the study for?

This trial is for individuals diagnosed with or suspected to have autoimmune epilepsy, as well as healthy people without epilepsy. Participants must be able to manage smart devices and not have open wounds near monitoring sites or cognitive conditions that would limit cooperation.Check my eligibility

What is being tested?

The study is testing wearable biosensors on patients with autoimmune epilepsy and healthy subjects. It aims to identify consistent changes in physical signals like heart rate, muscle activity, and brain waves before and during seizures.See study design

What are the potential side effects?

Since the intervention involves non-invasive wearable devices, side effects are minimal but may include discomfort from wearing the device or skin irritation at the site of wear.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with or suspected to have autoimmune epilepsy.

Select...

I do not have epilepsy and my cognitive functions are normal.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Reproducible changes in physiological biosignals

Number of high-quality physiological signals

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Autoimmune Epilepsy with BiosensorsExperimental Treatment1 Intervention

Subjects with suspected autoimmune epilepsy will wear biosensors on wrist or upper arm during the at home monitoring period.

Group II: Healthy Controls with BiosensorsActive Control1 Intervention

Neurologically normal adult healthy controls will wear biosensors on wrist or upper arm during the at home monitoring period.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,205 Previous Clinical Trials

3,766,744 Total Patients Enrolled

1 Trials studying Autoimmune Epilepsy

17 Patients Enrolled for Autoimmune Epilepsy

Benjamin Brinkmann, PhDPrincipal InvestigatorMayo Clinic

Media Library

Autoimmune Epilepsy with Biosensors Clinical Trial Eligibility Overview. Trial Name: NCT05627661 — N/A

Autoimmune Epilepsy Research Study Groups: Healthy Controls with Biosensors, Autoimmune Epilepsy with Biosensors

Autoimmune Epilepsy Clinical Trial 2023: Autoimmune Epilepsy with Biosensors Highlights & Side Effects. Trial Name: NCT05627661 — N/A

Autoimmune Epilepsy with Biosensors 2023 Treatment Timeline for Medical Study. Trial Name: NCT05627661 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research accommodate geriatric individuals?

"The criteria for partaking in this trial is individuals aged between 18 and 70. The clinicaltrials.gov website lists 171 studies targeting those below the age of majority, as well as 560 trials available to adults above 65 years old."

Answered by AI

Could I be a participant in this medical experiment?

"This research project is in need of 40 subjects between 18 and 70 years old, with either an autoimmune epilepsy diagnosis or no neurological conditions. Additionally, healthy participants must also apply for the trial to serve as a control group."

Answered by AI

Are there any opportunities to take part in this research presently?

"According to clinicaltrials.gov, this specific medical trial has ended its search for participants; the initial posting was on October 27th 2022 and the last edit took place November 16th 2022. Despite this study winding down, there are still over a thousand other trials that presently require volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

Benjamin H. Brinkmann 2022. "Wearable Devices to Monitor Seizures in Autoimmune Epilepsy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05627661.

All > Lgs Foundation